Introduction
Trigeminal neuralgia (TN) is a severe and debilitating condition characterized by intense, stabbing pain along the trigeminal nerve, typically affecting the face. Patients with TN often find themselves seeking emergency medical attention due to the sudden and excruciating nature of the pain. Managing trigeminal neuralgia in the emergency department (ED) requires a comprehensive understanding of the condition, prompt diagnosis, and effective intervention to alleviate the suffering of affected individuals.
What Is Trigeminal Neuralgia?
Trigeminal neuralgia is a medical condition characterized by severe, sudden-onset facial pain. This pain is often described as sharp, stabbing, or like an electric shock. It is caused by a trigeminal nerve dysfunction, which is responsible for transmitting sensations from the face to the brain. Trigeminal neuralgia can be triggered by routine activities such as talking, chewing, or touching the face. The condition is challenging and can significantly impact a person's quality of life due to the intensity and unpredictability of the pain.
What Is the Diagnosis of Trigeminal Neuralgia?
As per the International Classification of Headache Disorders (ICHD), specific guidelines have been established to diagnose Trigeminal Neuralgia (TN). These criteria include:
-
Experiencing a minimum of three episodes of one-sided facial pain that meets the conditions outlined in criteria B and C.
-
The pain should be localized in one or more divisions of the trigeminal nerve, with no spreading beyond this nerve's distribution.
-
The pain should exhibit at least three of the following four characteristics:
-
Recurring in sudden attacks lasting from a fraction of a second to two minutes.
-
Intense in severity.
-
Described as electric shock-like, shooting, stabbing, or sharp.
-
Triggered by harmless stimuli on the affected side of the face.
-
Absence of any detectable neurological impairment.
-
Ruling out other potential diagnoses.
What Is the Cause of Trigeminal Neuralgia?
The cause of pain in trigeminal neuralgia is still a topic of debate. One theory suggests that damage or disease to the trigeminal nerve increases nerve activity, and there might be a breakdown in the body's natural pain control mechanisms. Pain is felt when specific nerve cells in a part of the brain called the trigeminal nucleus interact with relay neurons in the thalamus. Some cases point to an abnormal path of the superior cerebellar artery or other small blood vessels compressing the facial nerve as the source of the problem. Interestingly, in approximately 85 percent of cases, no specific issue is identified despite thorough investigations, and the cause is termed idiopathic or classic by default.
Trigeminal neuralgia can also be triggered by various factors like aneurysms, tumors, chronic inflammation of the membranes surrounding the brain, or other abnormalities irritating the trigeminal nerve roots. In rare instances, the instigator may be demyelination caused by conditions like multiple sclerosis. Problems at the entry point of the trigeminal roots within the brainstem can lead to a similar pain syndrome. Uncommonly, dental fillings made of different metals or even, in one unusual case, a tongue piercing have been reported to provoke attacks. There is also a documented case of trigeminal neuralgia in a person with spontaneous intracranial hypotension; both conditions improved after surgical treatment of a defect in the covering of the nerves in the neck.
What Is the Treatment of Trigeminal Neuralgia?
In the emergency department (ED), the primary focus is on accurately identifying trigeminal neuralgia (TN), considering other possible causes of the symptoms, providing relief from pain, and ensuring appropriate follow-up care. Typically, individuals with trigeminal neuralgia do not visit the ED specifically for pain management due to the transient nature of the pain episodes. However, for those whose trigeminal neuralgia pain becomes constant or excessively frequent, causing significant impairment, the infusion of Phenytoin has been reported to be effective in interrupting these episodes. It is important to note that the evidence supporting this therapy is based on individual accounts rather than extensive clinical studies.
The primary drug for addressing facial pain, particularly in cases of trigeminal neuralgia, is an anticonvulsant that can be administered intravenously. Phenytoin, the initial medication discovered for treating trigeminal neuralgia, is commonly employed in emergencies. A recommended dosage is a 1-gram intravenous drip over 20 minutes, accompanied by continuous monitoring of electrocardiogram (EKG) and blood pressure. This method has shown efficacy in breaking the pain cycle in over 90 percent of cases. Fosphenytoin, an alternative to phenytoin, can also be considered. Subsequently, patients are advised to adhere to their prescribed oral anticonvulsant medications.
When Dilantin does not yield the desired results, two other anticonvulsant drugs, Levetiracetam and Lacosamide, can be administered intravenously. Although their efficacy in trigeminal neuralgia treatment has not been conclusively proven through trials, they belong to the same drug class and can be safely and rapidly loaded intravenously.
What Are the Crucial Points to Consider?
-
Neuropathic pain, particularly trigeminal neuralgia, typically does not respond well to opioids, narcotics, or standard analgesics.
-
Management often involves oral anticonvulsants, which may take days to weeks to reach therapeutic levels. Emergency department visits may be prompted by breakthrough pain, difficulty taking oral medications due to pain, or inadequate treatment with current medications.
Immediate Action Plan:
-
Administer 1 gram of intravenous Phenytoin over at least 20 minutes, with continuous EKG and blood pressure monitoring, to interrupt the pain cycle. Alternatively, Fosphenytoin, a Phenytoin equivalent, can be considered.
-
If Phenytoin is ineffective, Plan B involves intravenous administration of Levetiracetam at a dose of 1000 mg over five minutes, with EKG and blood pressure monitoring.
-
Plan C suggests intravenous administration of Lacosamide at 200 to 400 mg, along with EKG and blood pressure monitoring. If Phenytoin proves ineffective, levetiracetam or lacosamide can serve as suitable alternatives due to their shared classification of drugs and the ability to be rapidly administered intravenously.
Conclusion
In conclusion, effective management of Trigeminal Neuralgia in the emergency department necessitates a thorough understanding of its diagnosis and potential causes. While the exact cause remains elusive in many cases, emergency treatment primarily involves intravenous anticonvulsants like Phenytoin, with alternatives such as Levetiracetam and Lacosamide considered if necessary. Recognizing the limitations of opioids and the time required for oral medications to take effect, the immediate action plan emphasizes the timely administration of intravenous medications with continuous monitoring, providing a crucial approach to interrupt the debilitating pain cycle associated with Trigeminal Neuralgia.
